Tixagevimab and Cilgavimab (Evusheld) as Pre-exposure Prophylaxis for COVID-19 in Patients With Inflammatory Bowel Disease: A Propensity Matched Cohort Study
Desai et al., Crohn's & Colitis 360, doi:10.1093/crocol/otad047
https://c19early.org/desai3.html